Abstract.
To IT IS well known that marked abnormalities in the serum concentrations of thyroid hormones are seen in a variety of patients with acute and chronic nonthyroidal illness (NTI) [1] [2] [3] . Several studies indicated that the reduction of activity of iodothyronine (I) 5'-deiodinase is one of the most important factors underlying this phenomenon and a number of factors including decreased enzyme thiol cofactor in tissues [3] , the presence of an enzyme inhibitor, the local release of free fatty acids, and generation of free radicals, may contribute to the inhibition of extrathyroidal conversion of thyroxine (T4) [4] [5] [6] . However, the exact mechanism is not clear. As an enzyme inhibitor, Chopra et al. demonstrated the existence of a potent inhibitor of extrathyroidal conversion (IEC) of T4 to triiodothyronine (T3) in ether extracts of sera of some patients with a variety of systemic nonthyroidal illness and suggested that the nature of IEC in sera of NTI patients may be free fatty acid (FFA) [7] .
In this study, to clarify the relationship between IEC activity and serum FFA, we measured the serum concentrations of FFA and thyroid hormones and IEC activity in NTI patients and acute et al. 
Statistical analysis
Statistical analysis was carried out by one way analysis of variance followed by Scheffe's multiple comparisons, and a stepwise regression analysis was performed to evaluate the correlations between various parameters.
Results Table 1 shows the serum concentrations of T4, T3, T3/T4, IEC activities and the FFA in the 3 groups. In acute ketotic patients, the mean serum concentration of FFA was significantly higher than that in normal subjects (P<0.01). Although the T3/T4 ratio in the acute ketotic group was significantly lower than that in the control (P<0.01), affected by a higher T4 value (P<0.05) and a lower T3 value (P<0.05), the serum T3 concentrations in acute ketotic patients corresponded in general to the range of normal values. The IEC activity in the acute ketotic group was slightly lower than that in the control in spite of significantly high serum FFA values and a low T3/T4 ratio. In the low T3 group, the IEC activity did not increase despite a significant decrease in serum T3 (P<0.01) and the T3/T4 ratio (P<0.01). The mean serum FFA concentration in the low T3 group was higher than that in the control (P<0.05). In comparison with the acute ketotic group, there was a significant decrease in T4 (P<0.01), T3 (P<0.01) and the T3 /T4 ratio (P<0.01) in the low T3 group. However, the mean serum FFA value and IEC activity were not increased. Table 2 demonstrates the individual serum T4, T3 values, T4/T4 ratio, IEC activity and serum FFA in the low T3 group. IEC activity in case 1 was significantly high and beyond the range of assay. The four-fold diluted case 1 sample demonstrated 0.502mM of IEC activity. However, the case 1 serum FFA concentration was 1.182mM, which was lower than the mean FFA value for the acute ketotic group. Furthermore, case 4 IEC activity was 0.302mM in spite of a high serum concentration of FFA (2.002mM). In addition, IEC activity in low T3 patients, except for case 1, was relatively low in comparison with that in the other 2 groups and the serum FFA concentration in 3 of 7 samples was within the normal range. Figure 2 demonstrates the sequential changes in the serum T3 concentration, the T3/T4 ratio, IEC activity and the serum FFA concentration in 3 of 6 low T3 patients whom we could follow up. In these three patients, the serum FFA concentration decreased to various degrees as the serum T3 value increased. However, no significant change in IEC activity could be found. Table 3 shows the serum concentrations of FFA fractions in the 3 groups. In the acute ketotic group, all FFA fractions significantly increased. As reported previously, high serum FFA was predominantly unsaturated FFA, especially oleate. In the low T3 group, FFA fractions were intermediate values between those for control subjects and acute ketotic patients, but individual variance was very wide. Serum concentrations of palmitic, palmitoleic, oleic and arachidonic acids were significantly higher than in control subjects. However, there were no significant differences between low T3 there were also no correlations between serum T4 or T3/T4 ratio and IEC activities (data not shown).
Discussion
A previous study reported that patients with a low serum T3 concentration are exceedingly common and estimated to be about 70% of NTI patients [2] . On the other hand, the serum concentration of total FFA increases in patients with a variety of NTI and a good correlation is found between increased FFA values and poor patient outcome [13] [14] [15] . Interestingly, serum FFA, especially oleate, plays the role of thyroid hormone binding inhibitor (THBI) [13, 14] . Chopra et al. demonstrated that a potent IEC activity of T4 to T3 existed in ether extracts of sera of 8 or 40% of 20 NTI patients and the nature of IEC might be serum FFA because unsaturated FFAs inhibited the hepatic conversion of T4 to T3 in vitro and there was a significant correlation between the serum concentration of FFA and IEC activity in 6 IEC-negative and 4 IEC-positive patients.
They also reported that a significant correlation was observed between IEC and THBI activity [7] .
In this study, we demonstrate that no significant differences in IEC activity could be found among IOW T3, acute ketotic and control group, and IEC activities of low T3 patients, except for case 1, were relatively low in comparison with those in the other two groups. These findings suggest that serum T3 concentrations in many NTI patients bear no relation to in vitro IEC activity in ether extract of sera. Moreover, in vitro IEC activity did not correlate with serum concentration of T3, T4 and T3/T4 ratio. This is consistent with the findings of Gemma et al.; they demonstrated that there was no correlation between IEC activities and serum T3 concentrations in 140 NTI patients [19] . However, we consider that IEC activity is closely related to a reduction in the serum T3 concentration in some NTI patients because one patient in our low T3 group had strong IEC activity. Gemma et al. also demonstrated that patients with liver cirrhosis had a significant negative correlation between IEC activities and serum T3 concentrations despite even though there was no correlations in the patients with diabetes mellitus, respiratory failure and chronic renal failure [16] . This indicates that IEC may play an important role in reducing serum T3 in some illnesses.
From the standpoint of the severity of the illness, our patient with high IEC activity was a nonsurvivor, and all survivors had low IEC activities. However, other two nonsurvivors had also relatively low IEC. Gemma et al. revailed that the incidence of positive IEC of nonsurvivors (62.5%) was higher than that of survivors (37.5%) [16] . These suggest that IEC activity may depend on the severity of illness.
Next, we investigate the relationship between IEC activity and serum FFA concentration. In the acute ketotic group, the patients with significantly higher serum FFA concentrations had relatively lower IEC activities than the mean value of control group and there was no correlation between IEC activity and serum FFA concentration in 28 samples of the three groups. Furthermore, case 1 and 4 in low T3 group demonstrated the marked discrepancy between IEC activity and serum FFA concentration and follow-up of three patients in low T3 group revealed that there was no relationship between the sequential change in IEC activity and the serum FFA concentration. These findings suggest that IEC may not be caused by serum FFA only and includes several factors other than FFA. 
